Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Michael C Madigan"'
Autor:
Salim G. Habib, Dana B. Semaan, Elizabeth A. Andraska, Michael C. Madigan, Georges E. Al-Khoury, Rabih A. Chaer, Mohammad H. Eslami
Publikováno v:
Journal of Vascular Surgery. 77:e39-e40
Autor:
Salim Habib, Dana B. Semaan, Muhammad Saad Hafeez, Katherine M. Reitz, Michael C. Madigan, Eric Hager, Michael Singh, Ulka Sachdev, Ryan McEnaney, Rabih Chaer, Mo H. Eslami
Publikováno v:
Journal of Vascular Surgery. 77:e303
Autor:
Michael C. Madigan, Denis Rybin, Jeffrey J. Siracuse, Alik Farber, Jens Eldrup-Jorgensen, Gheorhge Doros, Mohammad H. Eslami, William P. Robinson
Publikováno v:
Journal of Vascular Surgery. 73:1715-1722
The choice of intervention for treating suprainguinal arterial disease, open bypass vs endovascular intervention, is often tempered by patient age and comorbidities. In the present study, we compared the association of patient age with 1-year major a
Autor:
Efthymios D. Avgerinos, Rabih A. Chaer, Lindsey Haga, Michael J. Singh, Michael C. Madigan, Xiaoyi Li, Elizabeth Andraska, Mohammad H. Eslami
Publikováno v:
Journal of Vascular Surgery. 72:1260-1268
Objective Retrograde open mesenteric stenting (ROMS) is an alternative to traditional bypass in patients who present with acute mesenteric ischemia (AMI). However, there is a paucity of data comparing outcomes of ROMS with other open surgical approac
Autor:
Zein Saadeddin, Abhisekh Mohapatra, Michael C. Madigan, Mohammad H. Eslami, Michel S. Makaroun, Georges E. Al-Khoury, Daniel J. Bertges
Publikováno v:
J Vasc Surg
Drug-coated balloons (DCB) and drug-eluting stents (DES) have significantly altered treatment paradigms for femoropopliteal lesions. We aimed to describe changes in practice patterns as a result of the infusion of these technologies into the treatmen
Autor:
Muhammad Saad Hafeez, Othman Abdul-Malak, Michael C Madigan, Nathan L Liang, Jeffrey J Siracuse, Mohammad H Eslami
Publikováno v:
Journal of the American College of Surgeons. 235:S105-S105
Autor:
Salim G. Habib, Dana B. Semaan, Muhammad-Saad Hafeez, Othman M. Abdul-Malak, Michael C. Madigan, Mohammad H. Eslami
Publikováno v:
Journal of Vascular Surgery. 75:e178-e179
Autor:
Michael C. Madigan, Anthony J. Lewis, Nathan L. Liang, Robert Handzel, Eric Hager, Michel S. Makaroun, Rabih A. Chaer, Mohammad H. Eslami
Publikováno v:
Journal of Vascular Surgery. 76:239-247.e1
Although the current guidelines for the management of blunt traumatic aortic injury (BTAI) have recommended intervention for grade 2 injuries or higher, a national trend has occurred for aggressive endovascular treatment of low-grade BTAIs. Little is
Autor:
Michael C. Madigan, Michael J. Singh, Rabih A. Chaer, Michel S. Makaroun, Georges E. Al-Khoury
Publikováno v:
Journal of Vascular Surgery. 69:432-439
Objective Most type II endoleaks have a benign natural history, but 6% to 8% are associated with sac enlargement and respond poorly to treatment. Our aim was to evaluate whether these enlargements are associated with delayed or occult type I and III
Autor:
Efthymios D. Avgerinos, Michael C. Madigan, Natalie Sridharan, Kyle Markel, Mohammad H. Eslami
Publikováno v:
Journal of Vascular Surgery. 74:e356-e357